Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

7.700
-0.040-0.52%
Volume:2.29M
Turnover:17.66M
Market Cap:7.46B
PE:45.29
High:7.930
Open:7.590
Low:7.430
Close:7.740
52wk High:15.750
52wk Low:5.300
Shares:969.00M
HK Float Shares:969.00M
Volume Ratio:2.15
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.170
ROE:-6.43%
ROA:-4.42%
PB:3.85
PE(LYR):45.29
PS:11.64

Loading ...

Alphamab Oncology repurchases 1,681,000 shares

Reuters
·
Nov 07, 2025

Alphamab Oncology - to Repurchase Shares up to HK$30 Mln

THOMSON REUTERS
·
Nov 07, 2025

Alphamab Oncology (09966) Announces Share Repurchase Update

Bulletin Express
·
Nov 07, 2025

ALPHAMAB-B (09966) Repurchases 560,000 Shares for HK$5.261 Million on November 7

Stock News
·
Nov 07, 2025

Alphamab Oncology Files HKEX Disclosure on Repurchase of 560,000 Shares at HK$9.39 Each

Reuters
·
Nov 07, 2025

Alphamab Oncology's (HKG:9966) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Simply Wall St.
·
Nov 05, 2025

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31, 2025

HK Stock Buyback Summary | October 29

Stock News
·
Oct 29, 2025

Alphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million

Bulletin Express
·
Oct 28, 2025

ALPHAMAB-B (09966) Repurchases 320,000 Shares for HK$3.7684 Million on October 28

Stock News
·
Oct 28, 2025

Alphamab Oncology Files HKEX Disclosure on Repurchase of 320,000 Shares at HK$11.78 Each

Reuters
·
Oct 28, 2025

BRIEF-Alphamab Oncology Says JSKN003 Granted Fast Track Designation By U.S. FDA

Reuters
·
Oct 27, 2025

Alphamab Oncology (9966) Announces Key Fast Track Designation for JSKN003

Bulletin Express
·
Oct 27, 2025

ALPHAMAB-B (09966): JSKN003 Granted FDA Fast Track Designation for PROC Treatment

Stock News
·
Oct 27, 2025

Alphamab Oncology - Jskn003 Granted Fast Track Designation by U.S. FDA for Proc

THOMSON REUTERS
·
Oct 27, 2025

ALPHAMAB-B Grants 1.9902 Million Reward Shares

Deep News
·
Oct 27, 2025

Alphamab Oncology (SEHK:9966): Evaluating Valuation Following Recent Pullback and Strong Year-to-Date Gains

Simply Wall St.
·
Oct 27, 2025

ALPHAMAB-B (09966) Grants 1,990,200 Shares as Incentive

Stock News
·
Oct 24, 2025

Alphamab Oncology (9966) Announces Grant of 1,990,176 Award Shares Under Restricted Share Award Scheme

Bulletin Express
·
Oct 24, 2025

BRIEF-Alphamab Oncology says Jskn003 Granted Breakthrough Therapy Designation For Her2+ Advanced CRC

Reuters
·
Oct 20, 2025